1.
Full Text
Development of a Performance Prediction Program for EVs Powered by Lithium-ion Batteries
SAE technical paper series, Volume 970239.
The performance capabilities which hold the key to the acceptance of electric vehicles (EVs) includes range and acceleration. Range can be effectively extended...
Lithium-ion batteries | Lithium | Vehicle performance | Energy storage systems | Electric motors
Lithium-ion batteries | Lithium | Vehicle performance | Energy storage systems | Electric motors
eJournal
Clinical Therapeutics, ISSN 0149-2918, 2015, Volume 37, Issue 8, pp. 1632 - 1642
Abstract Purpose Alzheimer disease (AD) is a growing global health and economic issue as elderly populations increase dramatically across the world. Despite...
Internal Medicine | Medical Education | drug development | mild cognitive impairment (MCI) | Alzheimer disease (AD) | biomarker | early stage | Key words Alzheimer disease (AD) | CRITERIA | TRIALS | DEMENTIA | SAFETY | DRUG-DEVELOPMENT | MILD COGNITIVE IMPAIRMENT | NATIONAL INSTITUTE | RECOMMENDATIONS | DIAGNOSTIC GUIDELINES | PHARMACOLOGY & PHARMACY | ASSOCIATION WORKGROUPS | Neuroprotective Agents - therapeutic use | Global Health | Alzheimer Disease - prevention & control | Humans | Alzheimer Disease - drug therapy | Nootropic Agents - therapeutic use | Clinical Trials as Topic | Drug Approval | Biomarkers - blood | Research Design | Alzheimer Disease - blood | Alzheimer's disease | Drugs | Health care | Immunoglobulins | Candidates | Activities of daily living | Cognitive ability | Clinical trials | Patients | Success | Hypotheses | Alzheimers disease | Pharmaceutical industry | Dementia | Apoptosis
Internal Medicine | Medical Education | drug development | mild cognitive impairment (MCI) | Alzheimer disease (AD) | biomarker | early stage | Key words Alzheimer disease (AD) | CRITERIA | TRIALS | DEMENTIA | SAFETY | DRUG-DEVELOPMENT | MILD COGNITIVE IMPAIRMENT | NATIONAL INSTITUTE | RECOMMENDATIONS | DIAGNOSTIC GUIDELINES | PHARMACOLOGY & PHARMACY | ASSOCIATION WORKGROUPS | Neuroprotective Agents - therapeutic use | Global Health | Alzheimer Disease - prevention & control | Humans | Alzheimer Disease - drug therapy | Nootropic Agents - therapeutic use | Clinical Trials as Topic | Drug Approval | Biomarkers - blood | Research Design | Alzheimer Disease - blood | Alzheimer's disease | Drugs | Health care | Immunoglobulins | Candidates | Activities of daily living | Cognitive ability | Clinical trials | Patients | Success | Hypotheses | Alzheimers disease | Pharmaceutical industry | Dementia | Apoptosis
Journal Article
Journal of Nanoparticle Research, ISSN 1388-0764, 4/2016, Volume 18, Issue 4, pp. 1 - 9
Aerosol-type nanoparticle deposition (NPD) is a magical method to form a dense electroceramic film with a fine, nanoscale structure on a substrate surface by...
Electronic Ceramics | Ceramic Film | Optics, Optoelectronics, Plasmonics and Optical Devices | Physical Chemistry | Nanoparticle | Characterization and Evaluation of Materials | Material Science | Inorganic Chemistry | Flexible Electronics | Low-temperature Process | Nanotechnology
Electronic Ceramics | Ceramic Film | Optics, Optoelectronics, Plasmonics and Optical Devices | Physical Chemistry | Nanoparticle | Characterization and Evaluation of Materials | Material Science | Inorganic Chemistry | Flexible Electronics | Low-temperature Process | Nanotechnology
Journal Article
Journal of Pharmacology and Experimental Therapeutics, ISSN 0022-3565, 2014, Volume 350, Issue 3, pp. 589 - 604
Brexpiprazole (OPC-34712, 7-{4-[4-(1-benzothiophen-4-yl) piperazin-1-yl]butoxy}quinolin-2(1H)-one) is a novel drug candidate in clinical development for...
ATYPICAL ANTIPSYCHOTIC-DRUGS | 5-HT2A RECEPTOR ANTAGONISTS | D-3 RECEPTOR | SCHIZOAFFECTIVE DISORDER | HIGH-AFFINITY | SCHIZOPHRENIA | PHARMACOLOGY & PHARMACY | RAT-BRAIN | BINDING-SITES | PREFRONTAL CORTEX | ARIPIPRAZOLE | Cricetulus | Rats, Wistar | Humans | Male | Thiophenes - metabolism | Quinolones - pharmacology | Receptors, Dopamine D2 - metabolism | Dopamine Agents - chemistry | Dose-Response Relationship, Drug | Quinolones - chemistry | Dopamine - metabolism | Receptor, Serotonin, 5-HT1A - metabolism | CHO Cells | Cricetinae | Receptors, Dopamine D2 - agonists | Quinolones - metabolism | Rats | Thiophenes - pharmacology | Serotonin Agents - metabolism | Dopamine Agents - metabolism | Animals | Serotonin Agents - chemistry | Serotonin - metabolism | Cell Line, Tumor | Thiophenes - chemistry | Dopamine D2 Receptor Antagonists | Protein Binding - physiology
ATYPICAL ANTIPSYCHOTIC-DRUGS | 5-HT2A RECEPTOR ANTAGONISTS | D-3 RECEPTOR | SCHIZOAFFECTIVE DISORDER | HIGH-AFFINITY | SCHIZOPHRENIA | PHARMACOLOGY & PHARMACY | RAT-BRAIN | BINDING-SITES | PREFRONTAL CORTEX | ARIPIPRAZOLE | Cricetulus | Rats, Wistar | Humans | Male | Thiophenes - metabolism | Quinolones - pharmacology | Receptors, Dopamine D2 - metabolism | Dopamine Agents - chemistry | Dose-Response Relationship, Drug | Quinolones - chemistry | Dopamine - metabolism | Receptor, Serotonin, 5-HT1A - metabolism | CHO Cells | Cricetinae | Receptors, Dopamine D2 - agonists | Quinolones - metabolism | Rats | Thiophenes - pharmacology | Serotonin Agents - metabolism | Dopamine Agents - metabolism | Animals | Serotonin Agents - chemistry | Serotonin - metabolism | Cell Line, Tumor | Thiophenes - chemistry | Dopamine D2 Receptor Antagonists | Protein Binding - physiology
Journal Article
Journal of Nanoparticle Research: An Interdisciplinary Forum for Nanoscale Science and Technology, ISSN 1388-0764, 04/2016, Volume 18, Issue 4, p. 1
Journal Article
Psychopharmacology, ISSN 0033-3158, 02/2012, Volume 219, Issue 3, pp. 859 - 873
Journal Article
Scientific Reports, ISSN 2045-2322, 10/2016, Volume 6, Issue 1, p. 35593
The artificial photosynthesis technology known as the Honda-Fujishima effect, which produces oxygen and hydrogen or organic energy from sunlight, water, and...
HYDROGEN | TEMPERATURE | CONVERSION | MULTIDISCIPLINARY SCIENCES | EFFICIENCY | (GA1-XZNX)(N1-XOX) NANOCRYSTALS | WATER | RANGE | Electrodes | Nanoparticles | Solid solutions | Films | Energy | Tin oxide | Carbon dioxide | Tin | Sunlight | Photosynthesis | Powder | Glass substrates
HYDROGEN | TEMPERATURE | CONVERSION | MULTIDISCIPLINARY SCIENCES | EFFICIENCY | (GA1-XZNX)(N1-XOX) NANOCRYSTALS | WATER | RANGE | Electrodes | Nanoparticles | Solid solutions | Films | Energy | Tin oxide | Carbon dioxide | Tin | Sunlight | Photosynthesis | Powder | Glass substrates
Journal Article
Journal of Pharmacology and Experimental Therapeutics, ISSN 0022-3565, 2014, Volume 350, Issue 3, pp. 605 - 614
Brexpiprazole (OPC-34712, 7-{4-[4-(1-benzothiophen-4-yl)piperazin- 1-yl] butoxy} quinolin-2(1H)-one) is a novel serotonin-dopamine activity modulator with...
BLINK RATE | 5-HT1A RECEPTORS | CLINICAL-TRIALS | INDUCED DEFICITS | PHENCYCLIDINE-INDUCED IMPAIRMENT | OBJECT RECOGNITION | SCHIZOPHRENIA | PHARMACOLOGY & PHARMACY | RECEPTOR OCCUPANCY | DRUG ACTION | ARIPIPRAZOLE | Motor Activity - physiology | Serotonin - physiology | Rats, Wistar | Macaca fascicularis | Motor Activity - drug effects | Rats | Receptor, Serotonin, 5-HT1A - physiology | Male | Treatment Outcome | Avoidance Learning - physiology | Cognition - drug effects | Dose-Response Relationship, Drug | Receptor, Serotonin, 5-HT2A - physiology | Animals | Dopamine - physiology | Cognition - physiology | Receptors, Dopamine D2 - physiology | Avoidance Learning - drug effects | Antipsychotic Agents - pharmacology
BLINK RATE | 5-HT1A RECEPTORS | CLINICAL-TRIALS | INDUCED DEFICITS | PHENCYCLIDINE-INDUCED IMPAIRMENT | OBJECT RECOGNITION | SCHIZOPHRENIA | PHARMACOLOGY & PHARMACY | RECEPTOR OCCUPANCY | DRUG ACTION | ARIPIPRAZOLE | Motor Activity - physiology | Serotonin - physiology | Rats, Wistar | Macaca fascicularis | Motor Activity - drug effects | Rats | Receptor, Serotonin, 5-HT1A - physiology | Male | Treatment Outcome | Avoidance Learning - physiology | Cognition - drug effects | Dose-Response Relationship, Drug | Receptor, Serotonin, 5-HT2A - physiology | Animals | Dopamine - physiology | Cognition - physiology | Receptors, Dopamine D2 - physiology | Avoidance Learning - drug effects | Antipsychotic Agents - pharmacology
Journal Article
PeerJ, ISSN 2167-8359, 2013, Volume 2013, Issue 1, p. e214
To date, anticonvulsant effects of the plant cannabinoid, cannabidivarin (CBDV), have been reported in several animal models of seizure. However, these...
Cannabidivarin | Pentylenetetrazole | qPCR | Seizure | Cannabinoid | Epilepsy | MULTIDISCIPLINARY SCIENCES | Neuropeptide Y | Brain | Messenger RNA | Analysis | Genes | Seizures (Medicine) | Gene expression | Enzymes | Animal models | EGR-1 protein | Cortex | CCL3 protein | Pharmacology | Kinases | Latency | Animals | Brain research | Brain-derived neurotrophic factor | Fos protein | Rodents | Ligands | Hippocampus | Chemokines | Seizures
Cannabidivarin | Pentylenetetrazole | qPCR | Seizure | Cannabinoid | Epilepsy | MULTIDISCIPLINARY SCIENCES | Neuropeptide Y | Brain | Messenger RNA | Analysis | Genes | Seizures (Medicine) | Gene expression | Enzymes | Animal models | EGR-1 protein | Cortex | CCL3 protein | Pharmacology | Kinases | Latency | Animals | Brain research | Brain-derived neurotrophic factor | Fos protein | Rodents | Ligands | Hippocampus | Chemokines | Seizures
Journal Article
PLoS ONE, ISSN 1932-6203, 02/2016, Volume 11, Issue 2, p. e0147265
Animal models of acquired epilepsies aim to provide researchers with tools for use in understanding the processes underlying the acquisition, development and...
ENTORHINAL CORTEX | SEIZURES | TEMPORAL-LOBE EPILEPSY | GLUTAMATE | MULTIDISCIPLINARY SCIENCES | PILOCARPINE-INDUCED EPILEPSY | SPATIAL MEMORY | RECEPTORS | DEFICITS | ELECTRICAL STIMULATION | KETAMINE | Recurrence | Rats, Wistar | Humans | Status Epilepticus - pathology | Rats | Male | Disease Progression | Morbidity | Behavior, Animal | Animals | Status Epilepticus - mortality | Status Epilepticus - epidemiology | Disease Models, Animal | Models | Prognosis | Research | Seizures (Medicine) | Status epilepticus | Seizing | Brain | Health sciences | Animal models | Epilepsy | Memory | Mortality | Lithium | Pilocarpine | Electrophysiological recording | Ethics | Convulsions & seizures | Brain research | Rodents | Pharmacy | Brain damage | Life sciences | Laboratory animals | Drug dosages | Brain injury | Seizures
ENTORHINAL CORTEX | SEIZURES | TEMPORAL-LOBE EPILEPSY | GLUTAMATE | MULTIDISCIPLINARY SCIENCES | PILOCARPINE-INDUCED EPILEPSY | SPATIAL MEMORY | RECEPTORS | DEFICITS | ELECTRICAL STIMULATION | KETAMINE | Recurrence | Rats, Wistar | Humans | Status Epilepticus - pathology | Rats | Male | Disease Progression | Morbidity | Behavior, Animal | Animals | Status Epilepticus - mortality | Status Epilepticus - epidemiology | Disease Models, Animal | Models | Prognosis | Research | Seizures (Medicine) | Status epilepticus | Seizing | Brain | Health sciences | Animal models | Epilepsy | Memory | Mortality | Lithium | Pilocarpine | Electrophysiological recording | Ethics | Convulsions & seizures | Brain research | Rodents | Pharmacy | Brain damage | Life sciences | Laboratory animals | Drug dosages | Brain injury | Seizures
Journal Article
Journal of Microbiology, Immunology and Infection, ISSN 1684-1182, 2015, Volume 50, Issue 5, pp. 634 - 639
Abstract Background/Purpose Blood cultures for patients suspected of having bacteremia are standard practice, although several studies demonstrate that blood...
Infectious Disease | Medical Education | C-reactive protein | white blood cell count | blood culture | community-acquired infection | kidney transplantation | ADULT PATIENTS | INFECTIOUS DISEASES | COMMUNITY-ACQUIRED PNEUMONIA | GUIDELINES | MICROBIOLOGY | IMMUNOLOGY | WOMEN | EMERGENCY-DEPARTMENT | SERIOUS BACTERIAL-INFECTIONS | BACTEREMIA | SEVERITY | Humans | Middle Aged | Male | Kidney Transplantation | Bacteremia - microbiology | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Bacteria - isolation & purification | Blood Culture - methods | Fever - blood | Outpatients | Community-Acquired Infections - drug therapy | Sensitivity and Specificity | Adult | Female | Urinary Tract Infections - microbiology | Retrospective Studies | Immunocompromised Host | Leukocyte Count - methods | C-Reactive Protein - analysis | Organ transplant recipients | Complications and side effects | Care and treatment | Transplantation | Kidneys | Bacteremia | Prevention | Medical examination
Infectious Disease | Medical Education | C-reactive protein | white blood cell count | blood culture | community-acquired infection | kidney transplantation | ADULT PATIENTS | INFECTIOUS DISEASES | COMMUNITY-ACQUIRED PNEUMONIA | GUIDELINES | MICROBIOLOGY | IMMUNOLOGY | WOMEN | EMERGENCY-DEPARTMENT | SERIOUS BACTERIAL-INFECTIONS | BACTEREMIA | SEVERITY | Humans | Middle Aged | Male | Kidney Transplantation | Bacteremia - microbiology | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Bacteria - isolation & purification | Blood Culture - methods | Fever - blood | Outpatients | Community-Acquired Infections - drug therapy | Sensitivity and Specificity | Adult | Female | Urinary Tract Infections - microbiology | Retrospective Studies | Immunocompromised Host | Leukocyte Count - methods | C-Reactive Protein - analysis | Organ transplant recipients | Complications and side effects | Care and treatment | Transplantation | Kidneys | Bacteremia | Prevention | Medical examination
Journal Article
Journal of Clinical Endocrinology and Metabolism, ISSN 0021-972X, 09/2013, Volume 98, Issue 9, pp. E1474 - E1482
Journal Article
Behavioural Pharmacology, ISSN 0955-8810, 12/2015, Volume 26, Issue 8 - Special Issue Pharmacological Approaches To The Study Of Social Behaviour - Part 3: Drug Effects On Social Behaviour, pp. 748 - 765
Deficiencies in social activities are hallmarks of numerous brain disorders. With respect to schizophrenia, social withdrawal belongs to the category of...
cannabidiol | dizocilpine (MK-801) | rat | Social interaction | risperidone | Short-term memory | recognition | Aripiprazole | Three-chamber apparatus | DOPAMINE-D-2 RECEPTOR | three-chamber apparatus | SCHIZOPHRENIC-PATIENTS | MORRIS WATER MAZE | COGNITIVE IMPAIRMENT | short-term memory | NEUROSCIENCES | NMDA RECEPTOR ANTAGONISTS | PARTIAL AGONIST | ATYPICAL ANTIPSYCHOTIC-DRUG | aripiprazole | social interaction | SPATIAL WORKING-MEMORY | BEHAVIORAL SCIENCES | PHARMACOLOGY & PHARMACY | ANIMAL-MODEL | EQUILIBRATIVE NUCLEOSIDE TRANSPORTER | Memory - drug effects | Receptors, N-Methyl-D-Aspartate - antagonists & inhibitors | Benzodiazepines - pharmacology | Receptors, Dopamine D2 - agonists | Risperidone - pharmacology | Rats | Serotonin 5-HT1 Receptor Agonists - pharmacology | Cannabidiol - pharmacology | Male | Serotonin Antagonists - pharmacology | Animals | Recognition (Psychology) - drug effects | Aripiprazole - pharmacology | Dopamine Antagonists - pharmacology | Social Behavior | Models, Animal | Dizocilpine Maleate - antagonists & inhibitors | Dizocilpine Maleate - pharmacology
cannabidiol | dizocilpine (MK-801) | rat | Social interaction | risperidone | Short-term memory | recognition | Aripiprazole | Three-chamber apparatus | DOPAMINE-D-2 RECEPTOR | three-chamber apparatus | SCHIZOPHRENIC-PATIENTS | MORRIS WATER MAZE | COGNITIVE IMPAIRMENT | short-term memory | NEUROSCIENCES | NMDA RECEPTOR ANTAGONISTS | PARTIAL AGONIST | ATYPICAL ANTIPSYCHOTIC-DRUG | aripiprazole | social interaction | SPATIAL WORKING-MEMORY | BEHAVIORAL SCIENCES | PHARMACOLOGY & PHARMACY | ANIMAL-MODEL | EQUILIBRATIVE NUCLEOSIDE TRANSPORTER | Memory - drug effects | Receptors, N-Methyl-D-Aspartate - antagonists & inhibitors | Benzodiazepines - pharmacology | Receptors, Dopamine D2 - agonists | Risperidone - pharmacology | Rats | Serotonin 5-HT1 Receptor Agonists - pharmacology | Cannabidiol - pharmacology | Male | Serotonin Antagonists - pharmacology | Animals | Recognition (Psychology) - drug effects | Aripiprazole - pharmacology | Dopamine Antagonists - pharmacology | Social Behavior | Models, Animal | Dizocilpine Maleate - antagonists & inhibitors | Dizocilpine Maleate - pharmacology
Journal Article
International Urology and Nephrology, ISSN 0301-1623, 7/2015, Volume 47, Issue 7, pp. 1117 - 1121
To compare the safety and efficacy of right-side and left-side retroperitoneoscopic donor nephrectomy (RDN) using our hybrid technique.We retrospectively...
Nephrology | Graft survival | Medicine & Public Health | Donor selection | Laparoscopic surgery | Living donors | Urology | Kidney transplantation | UROLOGY & NEPHROLOGY | KIDNEY | Postoperative Complications - etiology | Humans | Middle Aged | Male | Living Donors | Kidney Transplantation - methods | Nephrectomy - methods | Operative Time | Laparoscopy - methods | Laparoscopy - adverse effects | Retroperitoneal Space | Adult | Female | Retrospective Studies | Tissue and Organ Harvesting - adverse effects | Tissue and Organ Harvesting - methods | Length of Stay | Tissue and Organ Harvesting - statistics & numerical data | Japan | Nephrectomy - statistics & numerical data | Donor Selection - methods | Graft Survival | Postoperative Complications - epidemiology | Laparoscopy - statistics & numerical data | Transplant Donor Site - physiopathology | Nephrectomy - adverse effects | Laparoscopy
Nephrology | Graft survival | Medicine & Public Health | Donor selection | Laparoscopic surgery | Living donors | Urology | Kidney transplantation | UROLOGY & NEPHROLOGY | KIDNEY | Postoperative Complications - etiology | Humans | Middle Aged | Male | Living Donors | Kidney Transplantation - methods | Nephrectomy - methods | Operative Time | Laparoscopy - methods | Laparoscopy - adverse effects | Retroperitoneal Space | Adult | Female | Retrospective Studies | Tissue and Organ Harvesting - adverse effects | Tissue and Organ Harvesting - methods | Length of Stay | Tissue and Organ Harvesting - statistics & numerical data | Japan | Nephrectomy - statistics & numerical data | Donor Selection - methods | Graft Survival | Postoperative Complications - epidemiology | Laparoscopy - statistics & numerical data | Transplant Donor Site - physiopathology | Nephrectomy - adverse effects | Laparoscopy
Journal Article
Cancer Research, ISSN 0008-5472, 05/2016, Volume 76, Issue 9, pp. 2612 - 2625
The progression from precursor lesions of pancreatic cancer, including pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasm (IPMN),...
Oligonucleotide Array Sequence Analysis | Adenocarcinoma, Mucinous - pathology | Humans | Adenocarcinoma, Papillary - genetics | Transcriptome | Carcinoma, Pancreatic Ductal - genetics | Heterografts | Dual-Specificity Phosphatases - genetics | Carcinoma, Pancreatic Ductal - mortality | Pancreatic Neoplasms - mortality | Adenocarcinoma, Papillary - pathology | Adenocarcinoma in Situ - pathology | Adenocarcinoma in Situ - genetics | Dual-Specificity Phosphatases - metabolism | Neoplasm Invasiveness | Pancreatic Neoplasms - pathology | Kaplan-Meier Estimate | Pancreatic Neoplasms - genetics | Adenocarcinoma, Papillary - mortality | Carcinoma, Pancreatic Ductal - pathology | Mitogen-Activated Protein Kinase Phosphatases - genetics | Disease Progression | Adenocarcinoma, Mucinous - mortality | Microscopy, Confocal | Animals | Comparative Genomic Hybridization | Mice | Adenocarcinoma, Mucinous - genetics | Mitogen-Activated Protein Kinase Phosphatases - metabolism
Oligonucleotide Array Sequence Analysis | Adenocarcinoma, Mucinous - pathology | Humans | Adenocarcinoma, Papillary - genetics | Transcriptome | Carcinoma, Pancreatic Ductal - genetics | Heterografts | Dual-Specificity Phosphatases - genetics | Carcinoma, Pancreatic Ductal - mortality | Pancreatic Neoplasms - mortality | Adenocarcinoma, Papillary - pathology | Adenocarcinoma in Situ - pathology | Adenocarcinoma in Situ - genetics | Dual-Specificity Phosphatases - metabolism | Neoplasm Invasiveness | Pancreatic Neoplasms - pathology | Kaplan-Meier Estimate | Pancreatic Neoplasms - genetics | Adenocarcinoma, Papillary - mortality | Carcinoma, Pancreatic Ductal - pathology | Mitogen-Activated Protein Kinase Phosphatases - genetics | Disease Progression | Adenocarcinoma, Mucinous - mortality | Microscopy, Confocal | Animals | Comparative Genomic Hybridization | Mice | Adenocarcinoma, Mucinous - genetics | Mitogen-Activated Protein Kinase Phosphatases - metabolism
Journal Article
16.
Anticonvulsant potential of the phytocannabinoid, cannabidivarin, on epilepsy disease progression
2014
Epilepsy affects about 0.8% of individuals [1]. Many treatments are available but more effective and better-tolerated antiepileptic drugs (AEDs) with new...
Dissertation
International Journal of Endocrinology, ISSN 1687-8337, 2014, Volume 2014, pp. 436725 - 7
Aims. To evaluate the predictive power of pretransplant HbA1c for new-onset diabetes after transplantation (NODAT) in kidney transplant candidates, who had...
GLYCATED HEMOGLOBIN | SURVIVAL | HBA(1C) | FASTING PLASMA-GLUCOSE | GLYCEMIC CONTROL | LIFE-STYLE | TOLERANCE TEST | ENDOCRINOLOGY & METABOLISM | PATIENT | MELLITUS | GLYCOSYLATED HEMOGLOBIN | Prevention | Complications and side effects | Kidneys | Erythropoietin | Physiological aspects | Genetic aspects | Transplantation | Diabetes | Research | Risk factors
GLYCATED HEMOGLOBIN | SURVIVAL | HBA(1C) | FASTING PLASMA-GLUCOSE | GLYCEMIC CONTROL | LIFE-STYLE | TOLERANCE TEST | ENDOCRINOLOGY & METABOLISM | PATIENT | MELLITUS | GLYCOSYLATED HEMOGLOBIN | Prevention | Complications and side effects | Kidneys | Erythropoietin | Physiological aspects | Genetic aspects | Transplantation | Diabetes | Research | Risk factors
Journal Article